CareTrust REIT price target lowered to $32 from $37 at RBC Capital

RBC Capital analyst Michael Carroll lowered the firm’s price target on CareTrust REIT (CTRE) to $32 from $37 and keeps an Outperform rating on the shares after its Q4 results. The company remains well positioned to aggressively deploy capital accretively, and while the stock has been hampered by two overhangs including potential Medicaid cuts and PACS uncertainty, CareTrust is well positioned to navigate these concerns, the analyst tells investors in a research note.